Development of a commercialization plan for traumatic brain injury therapeutics

Information

• Research Project
• 9854752

• ApplicationId

  9854752

• Core Project Number

  R41NS110147

• Full Project Number

  3R41NS110147-01S1

• Serial Number

  110147

• FOA Number

  PA-19-029

• Sub Project Id

• Project Start Date

  4/29/2019 - 5 years ago

• Project End Date

  8/31/2019 - 5 years ago

• Program Officer Name

  FERTIG, STEPHANIE

• Budget Start Date

  4/29/2019 - 5 years ago

• Budget End Date

  8/31/2019 - 5 years ago

• Fiscal Year

  2019

• Support Year

  01

• Suffix

  S1

• Award Notice Date

  4/1/2019 - 5 years ago

Organizations

• AMERICAN LIFE SCIENCE PHARMACEUTICALS, INC.

Abstract This supplemental administrative grant will allow a three-person Company team to participate in the Information Corps (iCorps) program to accelerate commercialization of the Company?s predicate STTR Phase I grant technology, which is the development of a pharmaceutical treatment for traumatic brain injury. I-Corps is an intense eight-week entrepreneurial emersion course and requires the team to create a business canvas through conducting 100+ customer interviews. The team consists of the Company?s Chief Executive Officer, Medical Officer and the Principal Investigator of the predicate grant.

IC Name

• Activity

  R41

• Administering IC

  NS

• Application Type

  3

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  55000

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  853

• Ed Inst. Type

• Funding ICs

  NINDS:55000\

• Funding Mechanism

  SBIR-STTR RPGs

• Study Section

• Study Section Name

• Organization Name

  AMERICAN LIFE SCIENCE PHARMACEUTICALS

• Organization Department

• Organization DUNS

  170560960

• Organization City

  LA JOLLA

• Organization State

  CA

• Organization Country

  UNITED STATES

• Organization Zip Code

  920375149

• Organization District

  UNITED STATES